Table 3 Bivariate relationship analysis of participant characteristics with UT score
Variable | No Neuropathy (n = 351) | Neuropathy/no prior history of pathology or neuropathy with deformity (n = 234) | History of or current pathology (n = 314) | p |
|---|---|---|---|---|
Sex | Â | Â | Â | Â |
 Male | 150 (29.6) | 134 (26.5) | 222 (43.9) | < 0.0001a |
 Female | 201 (51.1) | 100 (25.4) | 92 (23.4) | |
Age | 65 (13.5) | 72 (10.7) | 66 (12.0) | < 0.0001a |
Diabetes type | ||||
 Type 1 | 26 (31.3) | 12 (14.5) | 45 (54.2) | < 0.0001a |
 Type 2 | 325 (39.8) | 222 (27.2) | 269 (33.0) | |
Diagnosed > 20 years+ | 45 (20.3) | 52 (23.4) | 125 (56.3) | < 0.0001a |
Current smoker | 50 (44.6) | 20 (17.9) | 42 (37.5) | 0.10 |
Knowledge of ideal HbA1c target (mmol/L) | ||||
  ≤ 7.5 | 169 (41.4) | 89 (21.8) | 150 (36.8) | 0.03a |
  > 7.5 or don’t know | 182 (37.1) | 145 (29.5) | 164 (33.4) | |
IRSD decile (median (IQR)) | 3 (2–4) | 3 (2–4) | 3 (2–5) | 0.33 |
Rurality of residence | Â | Â | Â | Â |
 Inner regional | 223 (39.1) | 166 (29.1) | 182 (31.9) | 0.01a |
 Outer regional | 111 (37.9) | 58 (19.8) | 124 (42.3) | |
 Remote or very remote | 17 (48.6) | 10 (28.6) | 8 (22.9) | |
State of Residence | ||||
 Tasmania | 159 (35.9) | 74 (16.7) | 210 (47.4) | < 0.0001a |
 Victoria | 192 (42.1) | 160 (35.1) | 104 (22.8) | |